TW202302121A - 近視之治療 - Google Patents

近視之治療 Download PDF

Info

Publication number
TW202302121A
TW202302121A TW111104966A TW111104966A TW202302121A TW 202302121 A TW202302121 A TW 202302121A TW 111104966 A TW111104966 A TW 111104966A TW 111104966 A TW111104966 A TW 111104966A TW 202302121 A TW202302121 A TW 202302121A
Authority
TW
Taiwan
Prior art keywords
copper
composition
administered
myopia
containing agent
Prior art date
Application number
TW111104966A
Other languages
English (en)
Chinese (zh)
Inventor
巴拉穆拉利 安巴蒂
莎拉 A 摩洛基亞
Original Assignee
猶他大學研究基金會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 猶他大學研究基金會 filed Critical 猶他大學研究基金會
Publication of TW202302121A publication Critical patent/TW202302121A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
TW111104966A 2021-02-11 2022-02-10 近視之治療 TW202302121A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163148344P 2021-02-11 2021-02-11
US63/148,344 2021-02-11

Publications (1)

Publication Number Publication Date
TW202302121A true TW202302121A (zh) 2023-01-16

Family

ID=82837328

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111104966A TW202302121A (zh) 2021-02-11 2022-02-10 近視之治療

Country Status (9)

Country Link
US (1) US20240122974A1 (cg-RX-API-DMAC7.html)
EP (1) EP4291163A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024508706A (cg-RX-API-DMAC7.html)
KR (1) KR20240021734A (cg-RX-API-DMAC7.html)
CN (1) CN118234482A (cg-RX-API-DMAC7.html)
AU (1) AU2022220331A1 (cg-RX-API-DMAC7.html)
CA (1) CA3208185A1 (cg-RX-API-DMAC7.html)
TW (1) TW202302121A (cg-RX-API-DMAC7.html)
WO (1) WO2022174094A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11524032B2 (en) * 2018-01-05 2022-12-13 University Of Utah Research Foundation Treatment of myopic progression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058015A1 (en) * 2000-06-01 2004-03-25 Yuanjin Tao Compositions and methods for treating eye discomfort and eye disease
US20040001791A1 (en) * 2000-11-16 2004-01-01 Zeiler Kenneth T. Composition, method of use, and devices for the treatment of onychomycosis
US9504603B2 (en) * 2012-04-02 2016-11-29 Ocuject, Llc Intraocular delivery devices and methods therefor
CA3246118A1 (en) * 2013-10-07 2025-02-21 Ocuject, Llc Intraocular delivery devices and methods therefor
ES2959242T3 (es) * 2016-03-08 2024-02-22 Univ Utah Res Found Agentes de reticulación y métodos asociados
US11524032B2 (en) * 2018-01-05 2022-12-13 University Of Utah Research Foundation Treatment of myopic progression
CN109776623B (zh) * 2019-03-05 2021-05-07 潍坊科技学院 一种含氟草酰胺同/异核化合物的制备方法与应用

Also Published As

Publication number Publication date
KR20240021734A (ko) 2024-02-19
CN118234482A (zh) 2024-06-21
US20240122974A1 (en) 2024-04-18
WO2022174094A1 (en) 2022-08-18
EP4291163A4 (en) 2025-01-01
CA3208185A1 (en) 2022-08-18
AU2022220331A1 (en) 2023-09-28
JP2024508706A (ja) 2024-02-28
EP4291163A1 (en) 2023-12-20

Similar Documents

Publication Publication Date Title
JP2023153926A (ja) 交差架橋剤、及び関連する方法
US12544400B2 (en) Treatment of myopic progression
JP2025028826A (ja) 乱視の治療
AU2020311441B2 (en) Multi-agent ocular formulations and treatment methods
US20240122974A1 (en) Treatment of myopia
RU2820596C2 (ru) Композиции оксиметазолина и способы для лечения офтальмологических расстройств
TW202547498A (zh) 用於治療老花眼的組合物、方法和系統
TW202412751A (zh) 含有udca或其鹽之水性醫藥組合物
HK40100508A (en) Oxymetazoline compositions and methods for treating ocular disorders
NZ614719A (en) Compositions and methods for non-surgical treatment of ptosis
NZ614719B2 (en) Compositions and methods for non-surgical treatment of ptosis